VICTOR: A phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection
Main Authors: | Kerr, D, Dunn, J, Langman, M, Smith, J, Midgley, R, Iveson, C, McConkey, C |
---|---|
Format: | Journal article |
Published: |
2008
|
Similar Items
-
VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION
by: Midgley, R, et al.
Published: (2008) -
Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.
by: Midgley, R, et al.
Published: (2010) -
Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.
by: Kerr, D, et al.
Published: (2007) -
The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.
by: Huijbers, A, et al.
Published: (2013) -
The NSAID roller coaster: more about rofecoxib.
by: Aronson, J
Published: (2006)